Digital
20th - 21st May 2021

5th Annual MarketsandMarkets Bioprocessing of Biotherapeutics-UK,EU & APAC-Virtual (Time zone- GMT)

After the successful foureditions of Bioprocessing of Cell therapies, coming up with 5th Annual of Bioprocessing of Biotherapeutics brings together leading bioprocessing scientists to share day-to-day challenges and practical solutions for the development, manufacture and quality of protein expressions, cell, and gene therapies.

The virtual event will present detailed case studies and interactive discussions in cell culture, scale-up, continuous processing, recovery, purification, process and product characterization, and formulation.

WHAT TO EXPECT

Key Highlights

  • Cell culture and bioproduction
  • Supply of lentiviral viral vectors
  • Cell therapy manufacturing
  • Close manufacturing practices
  • Car-T manufacturing
  • Automation & digitization
  • Inventory supply chain logistics
  • Bioreactor process: Autologous-single use manufacturing

Who Should Attend?

VPs, heads, directors, managers, leaders, engineers, scientists, working in 

  • Cell Culture
  • Cell Therapy
  • Upstream Processing
  • Stem Cell therapy
  • Process Development
  • Bioprocessing
  • Downstream Processing
  • Quality Control
  • Bioengineering
  • Downstream Processing
  • Quality Control
  • Bioengineering
  • Translational Sciences
  • Scale-up/out
  • Bioprocess development

CONFERENCE AGENDA

Online registrations

08:15 - 08:45

Opening note by MarketsandMarkets

08:45 - 08:55

Opening remarks by Chairperson

08:55 - 09:00
CELL CULTURE & BIOPRODUCTION

Process Design for AAV-based Gene & Cell Therapy Vectors towards Commercialization

09:00 - 09:30 Barbara Kraus, Head of Gene Therapy Process Development, Takeda

Developing a clinical grade manufacture of CYAD-101, a non-gene edited allogeneic NKG2D-based CAR T cell therapy for the treatment of solid malignancies

09:30 - 10:00 Emilie Gauthy, R&D Manager CMC and Process Development, Celyad

Introducing Stem Cell-Specific Dosing for Better Stem Cell and Gene Therapies

10:00 - 10:30 James L. Sherley, Founder & CEO, Asymmetrex LLC
UPSTREAM BIOPROCESSING & MANUFACTURING

Understanding the Regulatory and practical benefits of clonally-derived workflows

10:30 - 11:00 Duncan Borthwick, Global Marketing Manager, Solentim

Networking break & one on one meeting

11:00 - 11:20

Automation and digitalization of cell therapy manufacturing

11:20 - 11:50 Hemant Dhamne , Head of Vector and CAR-T Cell Processing, Immuneel Therapeutics Pvt Ltd

A new single-cell cloning and imaging platform and scale-down bioreactors for generating high producer cell lines with >99.99% monoclonality

11:50 - 12:20 Elly Sinkala, Lead Application Scientist, Cytena

Developing the world’s first triple antigen Virus Like Particle (VLP) against SARS CoV-2 virus, and oral delivery

12:20 - 12:50 Prabuddha Kundu, Co-founder & Managing Director,  Premas Biotech

Closing Remarks

13:20 - 13:25

End of Day 1

13:25 - 13:25

Online registrations

08:15 - 08:45

Opening note by MarketsandMarkets

08:45 - 08:55

Opening remarks by Chairperson

08:55 - 09:00 Stefano Baila, Director of Operations & Business Development, Anemocyte
DOWNSTREAM BIOPROCESSING & MANUFACTURING

Stem Cells & Regenerative Medicine : An Emerging Opportunity for Indian Life Sciences & Health-Care Ecosystem

09:00 - 09:20 Vishal Gandhi, Founder & CEO, Biorx Venture Advisors Pvt. Ltd

About the hurdles of cell therapy manufacturing for a clinical trial

09:20 - 09:50 Jenny Prange, Chief Scientific Officer, MUVON Therapeutics AG

Stem cell & Regenerative Medicine in Infertilty

09:50 - 10:20 Prabhu Chandra Mishra, Head, Department of Regenerative Medicine, Stemmax Research & Therapeutics Pvt Ltd

Networking & One on one meeting

10:20 - 10:45
ANALYTICS, REGULATORY & SUPPLY CHAIN

Cell therapy standardisation:

10:45 - 11:15 Elsa Branches, Interim Head-Advanced Therapies, Medicines and Healthcare Products Regulatory Agency

Overcoming the bottle neck of autologous manufacturing by adaptive culturing and sensor based automation

11:15 - 11:45 Ohad Karneili, Founder & CEO, Adva Biotechnology

Plasmids and other underestimated challenges and opportunities for cell gene-modification

11:45 - 12:15 Stefano Baila, Director of Operations & Business Development, Anemocyte

End to end logistics and inventory management of biotherapeutics

12:15 - 12:45 Fabio D'Agostino, Venture Partner-Cell Gene Therapy expert, Claris Ventures SGR SpA

Closing Remarks

12:45 - 12:50

End of Conference

12:50 - 12:50
Enquire Now

Sponsor/Exhibit Delegate
CONFERENCE SPEAKERS
Speakers
Stefano Baila
Stefano Baila
Director of Operations & Business Development, Anemocyte
Ohad Karneili
Ohad Karneili
Founder & CEO, Adva Biotechnology
Hemant Dhamne
Hemant Dhamne
Head of Vector and CAR-T Cell Processing, Immuneel Therapeutics Pvt Ltd
Barbara Kraus
Barbara Kraus
Head of Gene Therapy Process Development, Takeda
Emilie Gauthy
Emilie Gauthy
R&D Manager CMC and Process Development, Celyad
James L. Sherley
James L. Sherley
Founder & CEO, Asymmetrex LLC
Vishal Gandhi
Vishal Gandhi
Founder & CEO, Biorx Venture Advisors Pvt. Ltd
Fabio D'Agostino
Fabio D'Agostino
Venture Partner-Cell Gene Therapy expert, Claris Ventures SGR SpA
Please contact [email protected] for speaking opportunity
SPONSORS
Gold
example-image

Asymmetrex

Sponsors & Exhibitors
example-image

GenScript

Visiting Partners
example-image

Tosoh Corporation

example-image

Ecolab Life Sciences

example-image

Crowell & Moring

example-image

Greiner Bio-One

Speaking Partner
example-image

Cytena

example-image

Solentim

example-image

Namocell

example-image

Premas Biotech

PARTNERS
Supporting Association
Irish Stem Cell Foundation

Irish Stem Cell Foundation

BIO Rx

BIO Rx

BIO Rx strategic Leadership Alliance

BIO Rx strategic Leadership Alliance

Media Partners
example-image

PharmaVOICE

example-image

PharmaTutor

example-image

Pharma Journalist

example-image

Gene Therapy Net

example-image

Pharma China

PAST EVENT GALLERY
  • Networking-Room
  • Networking-Event
  • Networking-Exhibition-Audience
  • Networking-Exhibition
  • Discussion-Conference-Audience
  • Conference-Speaker
  • Conference-Audience-Discussion
  • Conference-Room-Audience
  • Conference-Room
  • Conference-Audience
  • High Potent Medicines Conference - Networking area
  • High Potent Medicines Conference - Exhibition Area - Booths